INONGAN

This brand name is authorized in France

Active ingredients

The drug INONGAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Methyl salicylate UNII LAV5U5022Y - METHYL SALICYLATE
Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet. Read about Methyl salicylate
2 Camphora UNII 5TJD82A1ET - CAMPHOR (SYNTHETIC)
Read about Camphora

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AC	Preparations with salicylic acid derivatives	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63263986

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.